11-88337557-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_001814.6(CTSC):c.116G>C(p.Trp39Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000019 in 1,576,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001814.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSC | NM_001814.6 | c.116G>C | p.Trp39Ser | missense_variant | Exon 1 of 7 | ENST00000227266.10 | NP_001805.4 | |
CTSC | NM_001114173.3 | c.116G>C | p.Trp39Ser | missense_variant | Exon 1 of 4 | NP_001107645.1 | ||
CTSC | NM_148170.5 | c.116G>C | p.Trp39Ser | missense_variant | Exon 1 of 4 | NP_680475.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000107 AC: 2AN: 187450Hom.: 0 AF XY: 0.00000994 AC XY: 1AN XY: 100562
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1424558Hom.: 0 Cov.: 32 AF XY: 0.00000142 AC XY: 1AN XY: 705038
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74370
ClinVar
Submissions by phenotype
Papillon-Lefèvre syndrome Pathogenic:1
- -
Papillon-Lefèvre syndrome;C1855627:Haim-Munk syndrome;C4551681:Periodontitis, aggressive 1 Pathogenic:1
This sequence change replaces tryptophan, which is neutral and slightly polar, with serine, which is neutral and polar, at codon 39 of the CTSC protein (p.Trp39Ser). This variant is present in population databases (rs104894210, gnomAD 0.01%). This missense change has been observed in individual(s) with Papillon-Lefevre syndrome (PMID: 11180012). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 7296). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Trp39 amino acid residue in CTSC. Other variant(s) that disrupt this residue have been observed in individuals with CTSC-related conditions (PMID: 27062382), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
CTSC-related disorder Uncertain:1
The CTSC c.116G>C variant is predicted to result in the amino acid substitution p.Trp39Ser. This variant has been reported in the homozygous state in four individuals with Papillon-Lefevre syndrome from the same family (Family 1, Nakano et al. 2001. PubMed ID: 11180012). This variant is reported in 0.011% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Of note, another variant impacting the same amino acid [c.117G>T (Trp39Cys)] has also been reported in the homozygous state in an individual with Papillon-Lefevre syndrome (Tekin et al. 2016. PubMed ID: 27062382). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at